Remimazolam for the prevention of emergence agitation in adults following nasal surgery under general anesthesia: a prospective randomized clinical controlled trial

Abstract Background Remimazolam is a novel intravenous sedative/anesthetic drug that belongs to the ultra-short-acting class of benzodiazepines. The purpose of this study was to evaluate the effectiveness of postoperative use of remimazolam in preventing emergence agitation (EA) in adults following...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yanfei Lu, Qiaomin Xu, Hong Dai, Jimin Wu, Mengting Ai, Haiyan Lan, Xiaoli Dong, Gongchen Duan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-01-01
coleção:	BMC Anesthesiology
Assuntos:	Remimazolam Nasal surgery Emergence agitation General anesthesia
Acesso em linha:	https://doi.org/10.1186/s12871-024-02875-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!